GI COMPANY INC has a total of 17 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Argentina. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are EU SOL BIOTECH CO LTD, BERTOLINI ALFIO and SOSEI R&D LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Argentina | 2 | |
#4 | China | 2 | |
#5 | Taiwan | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Mexico | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Syringes | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Barker Nicholas P | 13 |
#2 | Podolsky Daniel K | 3 |
#3 | Woon Chee-Wai | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008133928A2 | Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders | |
WO2008130591A2 | Using trefoil polypeptides to treat eye lesions associated with ophthalmic procedures | |
US2007148733A1 | Yeast expression vectors for production of ITF | |
CN101223421A | Oral drug delivery system and methods of use thereof | |
EP1581623A2 | Trefoil domain-containing polypeptides and uses thereof | |
TW200410708A | Trefoil domain-containing polypeptides and uses thereof | |
MXPA05002476A | Modified asialo-interferons and uses thereof. |